OnePointTwo Capital Ventures LLC 4

What Happened
OnePointTwo Capital Ventures LLC (listed as a 10% owner) purchased 422,500 shares of Conexeu Sciences Inc. (CXNU) on May 12, 2026 at $0.80 per share, a cash outlay of $338,000. The same Form 4 also reports two related derivative entries for 422,500 shares each recorded at a $0.00 per-share price with a nominal reported amount of $423 — one recorded as a sale (S) and one as a purchase (P). The outright purchase is a direct acquisition of common stock (typically a more informative, bullish indicator than a sale); the zero-price derivative lines appear to be record-keeping entries for derivative instruments (conversion/exercise/transfer), but the filing does not detail the exact mechanics.

Key Details

• Transaction date: May 12, 2026. Primary purchase: 422,500 shares @ $0.80 = $338,000.
• Derivative entries (same date): two 422,500-share entries at $0.00 with reported cash amount $423 (one coded S, one coded P) — classified as derivative transactions in the filing.
• Insider: OnePointTwo Capital Ventures LLC — reported as a 10% owner (institutional holder, not an executive).
• Shares owned after the transaction: not disclosed in the Form 4.
• Filing: submitted May 14, 2026 — appears to be filed within the normal 2-business-day window (timely).
• Transaction codes: P = purchase, S = sale; the $0.00 derivative lines likely reflect instrument conversion/exercise or bookkeeping entries (filing gives no further detail).

Context
Because the filer is a 10% institutional owner rather than a company insider executive, this is institutional-level buying activity. The straight purchase for $338K is the clearest signal of added stake; derivative entries at $0.00 should be read as technical reporting entries unless the filing provides more detail. As always, purchases are factual disclosures — they don't prove future performance.